Clinical trial
A Study of Taurine in Patients With First-episode Psychosis Receiving…
NCT00420823 · Melbourne Health, Other · Completed
Key facts
| NCT number | NCT00420823 |
|---|---|
| Title | A Study of Taurine in Patients With First-episode Psychosis Receiving Antipsychotic Treatment |
| Official title | A 12-week, Parallel, Double-blind, Randomised, Placebo-controlled Adjunctive Study of Taurine 4 Grams in 128 Patients With First-episode Psychosis Receiving Antipsychotic Treatment. |
| Lead sponsor | Melbourne Health, Other |
| Collaborators | Stanley Medical Research Institute Southern Health |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Psychotic Disorders |
| Intervention type | Drug |
| Interventions | Taurine 4g |
| Enrollment | 121 |
| Start date | Jan 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2010 |
| First posted | Jan 11, 2007 |
| Last update posted | Nov 20, 2015 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: